期刊文献+

单核细胞趋化蛋白-1小分子干扰RNA真核表达质粒的构建及意义

Construction eukaryotic expression vector of MCP-1 siRNA
原文传递
导出
摘要 目的构建单核细胞趋化蛋白-1(MCP-1)小分子干扰RNA(siRNA)表达载体,为进一步研究其对动脉粥样硬化(AS)的防治作用提供手段。方法设计并合成两端含有酶切位点两条DNA序列,经退火成互补双链,再克隆至载体pSi-lencer 2.0-U6中构建重组表达载体,转化DH-5α菌株,提取质粒行双酶切鉴定,并进行序列测定。结果双酶切证实MCP-1 siRNA表达载体克隆构建成功,插入片段测序结果与合成的siRNA结果一致。结论成功构建MCP-siRNA表达载体,为动脉粥样⒉化的防治奠定实验基础。 Objective To construct the small interfering RNA(siRNA) expression vector for monocyte chemotactite protein-1(MCP-1) and provide ways for artery stenosis treatment. Methods Two DNA sequences containing the sites of restriction endonuclease at both ends were designed and synthesized. The eomplement form was obtained by annealing and being cloned into vector pSilencer2.0-U6 and the recombinant plasmid was transformed into strain DH-5 α. The plasmid identified by restriction enzyme was used for sequencing. Results MCP-1 siRNA expression vector was successfully constructed and identified by double endonuclease digestion. Sequence analysis of the inserted fragment revealed the salne sequence as that of the synthesized siRNA oligonucleotides. Conclusion MCP-1 siRNA expression vector has been successfully constructed, which lays the basis for its application in the prevention and treatment of artery stenosis.
出处 《中华普通外科学文献(电子版)》 2008年第5期10-12,共3页 Chinese Archives of General Surgery(Electronic Edition)
基金 广东省科技计划重点引导项目资助(2005B31201001) 教育部高等学校博士点专项基金项目资助(20050558053)
关键词 单核细胞趋化蛋白-1 小分子干扰RNA pSilencer 2.0-U6 构建 Monocyte chemotactite protein- 1 Small interfering RNA pSilencer 2.0-U6 Construction
  • 相关文献

参考文献10

  • 1Brott TG,BrowmRD Jr,Meyer FB,et al.Carotid revascularization for prevention of stroke:carotid endarterctomyand carotid artery stenting[].Mayo Clinic Proceedings.2004
  • 2AndaluzN,ZuccarelloM.Evidenc-based surgical treatment ofcarotid stenosis.Literature review[].J NeurosurgSci.2004
  • 3IshimotoT,TakeiY,YuzawaY,etal.Downregulation ofmonocytechemoattractant protein-1involvingshort interferingRNAattenuates hapten-induced con-tact hypersensitivity[].Molecular Therapy.2008
  • 4Nelken NA,Coughlin SR,Gordon D,et al.Monocyte chemoattractant protein-1 in human atheromatous plaques[].Journal of Clinical Investigation The.1991
  • 5Yla-Herttuala S,Lipton BA,Rosenfeld ME,et al.Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions[].Proceedings of the National Academy of Sciences of the United States of America.1991
  • 6Paddison PJ,Hannon GJ.siRNA and shRNAs: skeleton keys to the human genome[].Current Opinion in Molecular Therapeutics.2003
  • 7Brummelkamp TR,Bernards R,Agami R.Stable suppression oftumorigenicity by virus-mediated RNA interference[].Cancer Cell.2002
  • 8Xia XG,Zhou H,Ding H,et al.Anenhanced U6promoterfor syn-thesis of short hairpin RNA[].Nucleic Acids Research.2003
  • 9Dykxhoorn DM,Novina CD,Sharp PA.Killing the messenger:short RNAs that silence gene expression[].Nature Reviews Molecular Cell Biology.2003
  • 10Yu JY,DeRuiter SL,Turner DL.RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells[].Proceedings of the National Academy of Sciences of the United States of America.2002

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部